`
`Lacosamide Induced Psychosis: Case Report, Review of Differential Diagnosis and Relevant Pharmacokinetics. - PubMed - NCBI
`
`PubMed
`
`Format: Abstract
`
`Full text links
`
`Clin Neuropharmacol. 2015 Sep-Oct;38(5):198-200. doi: 10.1097/WNF.0000000000000097.
`Lacosamide Induced Psychosis: Case Report, Review of Differential
`Diagnosis and Relevant Pharmacokinetics.
`1
`Pinkhasov A , Lam T, Hayes D, Friedman M, Singh D, Cohen H.
`Author information
`
`Abstract
`Lacosamide (LCM) is an antiepileptic medication used as an adjunctive treatment for partial
`seizures. Psychosis associated with LCM use is a rarely documented phenomenon, which may be
`difficult to detect in the context of the often complicated clinical presentation of epilepsy. We report
`the development of psychosis in a young woman after the use of LCM, which subsequently resolved
`with its discontinuation. The possible differential diagnosis and pharmacokinetic nuances are
`discussed. This is the first case report of LCM-induced psychosis in the United States.
`
`PMID: 26366962 DOI: 10.1097/WNF.0000000000000097
`[PubMed - indexed for MEDLINE]
`
`Publication Types, MeSH Terms, Substances
`
`LinkOut - more resources
`
`PubMed Commons
`
`0 comments
`
`PubMed Commons home
`
`How to join PubMed Commons
`
`https://www.ncbi.nlm.nih.gov/pubmed/26366962
`
`1/1
`
`ARGENTUM Exhibit 1133
` Argentum Pharmaceuticals LLC v. Research Corporation Technologies, Inc.
`IPR2016-00204
`
`Page 00001